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a  b  s  t  r  a  c  t
Behc¸et’s disease (BD) is a multi-systemic vascular disorder characterized by oral and genital
ulcers, as well as cutaneous, ocular, arthritic, vascular, central nervous system and gastroin-
testinal involvement. It usually affects young adults, and its pathological origin is unknown.
The  case of a 47-year-old woman with recurrent ulcers in the oral cavity is presented. She
linked the pain with sitting and during the sexual act, with vaginal and oral cavity pain,
due  to the lesions present at those sites, as well as swelling and pain in the knees, mak-
ing  walk painful. The patient was kept under observation and underwent multidisciplinary
treatment with prescription of topical and systemic drugs to improve quality of life. Dentists
should be aware of BD and the need of multidisciplinary treatment to increase the patient’s
quality of life.
© 2014 SECOM. Published by Elsevier Espan˜a, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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r  e  s  u  m  e  n
La Enfermedad de Behc¸et (EB) es un trastorno vascular multi-sistémico caracterizado por
úlceras orales y genitales, cutáneas, oculares, artritis, y afectación vascular, sistema nervioso
central y gastrointestinal. Por lo general afecta a los adultos jóvenes y la etiopatogenia es
desconocida. Se presenta un caso de mujer de 47 an˜os de edad que presenta úlceras recor-rentes  en la cavidad oral. Ella ha relacionado com el dolor al sentarse, durante el acto sexual,
dolor vaginal y oral, cavidad, debido a las lesiones presentes en los lugares mencionados,
hinchazón y dolor em las rodillas causando diﬁcultad para caminar. El paciente se mantuvo
em  observación y se sometió a través de untratamientomultidisciplinariocon la prescrip-
ción de produtos farmacéuticos tópicos y sistémicos para mejorar la calidad de vida. El
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conocimiento del clínico sobre EB ayuda en el tratamento multidisciplinario de promoción
de  la calidad de vida para el paciente.
© 2014 SECOM. Publicado por Elsevier Espan˜a, S.L.U. Este es un artı´culo Open Access
-NC-bajo la CC BY
Introduction
Behc¸et’s disease was described by Hulusi Behcet in 1937 as
an inﬂammatory process of unknown etiology, characterized
by recurrent aphthous ulcers, genital ulcers, uveitis and cuta-
neous lesions. It is also associated with other less frequent
systemic manifestations, such as gastrointestinal, central ner-
vous system, vascular and joint infections.1
In 1990, the International Study Group for Behc¸et’s Disease2
established the existence of recurrent mouth ulcerations and
at least two additional clinical manifestations, which may
consist of recurrent genital ulcers, ocular lesions, arthritis,
thrombophlebitis, neurological abnormalities and cutaneous
lesions or positive pathergy test, which occurs in 40–80% of
the cases and is exclusive to this disease (sterile pustule cuta-
neous reaction after the injection of an inert substance) as key
points for diagnosing Behc¸et’s disease.3
The speciﬁc criteria proposed by the International Study
Group for Behc¸et speciﬁes those recurrent ulcers: smaller
naphtha’s, larger naphtha’s or herpetiform ulcers observed in
a minimum of three episodes during a period of 12 months,
and two of any of the following manifestations: recurrent gen-
ital ulcers (ulcers or genital ulcer scars); joint manifestations;
ocular lesions (anterior or posterior uveitis, or presence of cells
on the vitreo during ocular exam, or also retinal vasculitis);
cutaneous lesions (erythematosus nodules, pseudofolliculitis,
papular-pustulous lesions or also acneiform nodules observed
in post-adolescent patients not treated with corticosteroids);
analysis of the pathergy signal test (for 48 h).2–4
It seems to preferentially occur in individuals in their third
decade of life, although there is increasing rate of the disease
in children and there is no proof of hereditary factor. Men are
more  frequently affected than women. This condition’s prog-
nosis is severe especially in young men, without, however,
an explanation for this. The severity of the disease seems to
decrease while people age.5
The etiopathogeny seems to be related to an alteration
of the immunoregulation set off by one or various infec-
tious agents in genetically susceptible individuals. Some
histopathologic studies support the existence of an
immunologic mechanism mediated by cells, in which
the inﬁltrates consist mainly of cooperative T lymphocytes
and macrophages in association with NK cells (Natural Killer
cells), in which the participation of both cell and humoral
immunity is suggested where, in response to the increase
in the number of cells, a reaction of hypersensitivity type
III occurs.6 Recent ﬁndings have both supported the signif-
icance of genetic factors and better deﬁned the nature of
inﬂammation in Behc¸et’s disease.7The evolutionary history of the disease is marked initially
by oral, followed by genital ulcers, ocular lesions skin disorders
and arthritis.3ND licencia (http://creativecommons.org/licencias/by-nc-nd/4.0/).
The involvement of major importance in this syndrome,
also being the ﬁrst manifestation perceived in between 25
and 75% of cases, are the oral lesions, which are manifested
in the same location during the entire course of the disease
in almost all patients. Such lesions are similar to the typical
aphthous ulcers that are characteristically presented in a
great number of lesions (six or more), occurring mainly on the
soft palate, lips, tongue, gingiva, oral mucosa and oropharynx,
while the larynx and the nasal mucosa are rarely affected.
When these lesions are individually present, they generally
vary in size, measuring from 2 to 10 mm in diameter, and
present with a yellowish necrotic base, raised edges and a
diffuse erythematosus area. Some studies have demonstrated
prevalence in the occurrence of larger aphthae in almost
40% of the patients with this syndrome.8 There may also be
herpetiform ulcers, which occur with greater frequency in
women. These ulcers persist for several days or even weeks,
and heal without leaving scars. Some studies have shown
that the oral severity of the lesions is not directly related to a
more  severe systemic involvement.4,8
The genital ulcers appear to be the second frequent man-
ifestation in the disease’s cases and are found in a large
majority of patients. The perianal lesions are found in both
gender and their evolution is similar to what occurs in the
mouth. Lesions on the penis and scrotum are rarely observed.
In women, lesions occur mostly on the lips, vulva and vaginal
wall, and may have painless manifestations that go unob-
served, and in these cases, the diagnosis is made through
pelvic examination.4,8
Skin lesions are present in forms of erythematosus nod-
ules, erythematosus papules, vesicles, pustules, pyoderma,
folliculitis and acneiform eruptions and are positive in the
pathergy test, developing a reaction one or two days after
injection of a cutaneous lesion hyper-reactivity similar to
a sterile pustule that is present in 40 and 80% of affected
patients.4
Posterior uveitis, retinal vasculitis, conjunctivitis, optic
neuritis and retinal arthritis are frequent ocular manifesta-
tions, but anterior uveitis with hypopyon (presence of pus in
the anterior chamber of the eye) is the classical manifestation
in the beginning of the Behc¸et’s syndrome. These ocular
lesions may be reversible, but they may evolve to a cataract or
glaucoma. The recurrence and gravity of these manifestations
lead to a high rate of patients becoming blind, which makes
necessary to perform an energetic and aggressive treatment
for this disease.9
The articular manifestations are present in over 50% of
the patients and may precede, accompany or follow other
manifestations of the Behc¸et’s syndrome. It is characterized
as monoarthritis or polyarthritis of an inﬂammatory and
non-erosive nature. Generally, the arthritis or arthralgia is
asymmetrical and polyarticular, and more  frequently attacks
the large joints such as knees, ankles, elbows and wrists, but
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he small joints may also be affected. Patients may relate
ultiple recurrent episodes of acute inﬂammatory arthritis,
imilar to arthropathy associated with inﬂammatory intesti-
al disease, although, in some cases the arthritis may become
hronic.10
Neurological manifestations occur due to inﬂamma-
ion of the central nervous system and are not very
requent, due to vascular involvement at the location
r because of peripheral polyneuropathy. The most fre-
uent forms occur due to meningoencephalitis, caused
y inﬂammation and not by an infection. The neurolog-
cal deﬁcits are characterized by sensitive disturbances,
yramidal syndrome, convulsions, cerebellum syndrome,
estibular syndrome and oculo-motor paralysis. The throm-
osis of small cerebral vessels, or large venous sinuses
s manifested by endocranial hypertension. Polyneuritis
re not often and when they occur, they are mani-
ested by mental confusion, psychiatric symptoms and
ementia.11
Vascular manifestations are presented as superﬁcial
hrombophlebitis, venous thromboses or as arteritis. These
rteritis are manifested by occlusive-thrombotic and aneuris-
atic phenomena that preferentially affect the aorta,
ulmonary artery, popliteal artery, femoral artery, subclavia
rtery and less frequently, the carotid artery. Thus, they are
esponsible for heart attack or hemorrhagic phenomena in
ifferent organs.12
Gastrointestinal manifestations preferentially attack the
ntestines and esophagus, and are manifested through
bdominal pain, diarrhea and occasionally by perforations.5
The authors consider that the main differential diagnoses
f Behc¸et’s syndrome are erythema multiforme or Stevens
ohnson Syndrome and Crohn’s disease, showing lesions in
ral and genital mucosa.5
The important point about Behc¸et’s syndrome is related
o its manifestations, which increases the importance of a
ulti-disciplinary treatment, as there are several treatment
ossibilities, including highly toxic approaches or physical
onditions that restrict the use of certain drugs.13 Currently
reatment varies according to the seriousness of each patient’s
anifestations, starting with simply informing, explaining
nd reassuring the patient.
Due to the absence of longitudinal studies and the reduced
umber of control groups, it is not possible to answer ques-
ions such as: what is the ideal moment to start a treatment,
uration and intensity of it, and what is the effect of a long
erm treatment, which compels a proposal based on evidence
Cochrane Collaboration).14
For oral manifestations in patients which present complex
phthous ulcers, therapeutic management must be started
ith topical pharmaceutics of the colchicine and dapsone
ype. If no response occurs with these drugs, orally admin-
stered thalidomide, prednisone and methotrexate may be
sed, always bearing in mind the degree of toxicity and
he adequate physical condition for the use of such drugs.
n more  severe cases, a combination of corticosteroides
ith immunosuppressors, such as cyclosporin, azathioprine,
yclophosphamide, interferon-alfa 2a or chlorambucil, may
e used; however, the need for multidisciplinary treatment is
equired because this is a systemic inﬁrmity.13,14 . 2 0 1 6;3  8(2):105–110 107
Case  report
The present report is of a female patient, 47 years old, referred
to Center for Study and Care of Special Patients (CEAPE) –
Paulista University – Indianapolis Campus – São Paulo – Brazil,
for the diagnosis and treatment of recurrent ulcers in the oral
cavity. The main complaint reported was pain when sitting,
during the sexual act, vaginal and oral cavity pain, due to
the clinical lesions present at those sites, with a duration of
approximately ﬁve months, with the condition of these man-
ifestations becoming exacerbated. She also reported that she
had ﬁve children and had ligation of the fallopian tubes per-
formed 20 years ago, and a hysterectomy 3 years previously
due to the formation of uterine myoma. In the anamnesis she
related that for the past 2 years she had suffered episodes of
oral and genital lesions, had sought medical attention and had
been treated for sexually transmittable disease.
On clinical intraoral exam, multiple ulcers were observed,
measuring approximately 0.5–1.2 cm in diameter, with the
presence of an erythematous halo and ﬁbrinolytic bed on the
edge and back of the tongue, lips and bilateral jugal mucosa
(Fig. 1a–f). An incisive biopsy was performed, and material was
collected for pathologic anatomy. The material collected was
located on the lateral edge of the tongue, ﬁxed in 10% formol,
and on macroscopic exam, the material showed a fragment of
irregular shaped tissue, measuring 0.4 cm × 0.2 cm × 0.2 cm,  of
grayish color, with an irregular surface and a ﬁrm elastic con-
sistency. On microscopic examination, the cuts revealed an
ulcerated lesion located in mucosa partially coated by parak-
eratinized stratiﬁed pavementous epithelium with signs of
hyperplasia and proliferation at the margin of the ulceration.
The subjacent tissue to the ulcer showed intense inﬂam-
matory inﬁltrate, rich in neutrophils close to the surface of
the lesion, where necrosis and a ﬁbrinous crust were noted.
Deeper down, mononuclear cells of unspeciﬁc chronic inﬂam-
mation were present, which also inﬁltrated the muscular
ﬁbers present at the deep base of the lesion which was well
vascularized. No histologic signs of malignity were observed.
The result was: larger and smaller recurrent aphthas (Sutton
or Mikulicz). The patient was medicated with Dexametasone
Elixir mouthwashes twice a day for 8 days. There was regres-
sion of the oral lesions, but by this time, she reported that the
genital manifestations and the condition of edema and pain
in the knees had intensiﬁed, making it very difﬁcult for her to
walk.
The patient was referred to the Specialized Butantã Atten-
dance Service of the Municipal Secretary for Health of São
Paulo, where a clinical gynecological exam was done, and
it was reported that the patient presented multiple ulcera-
tions in the posterior vaginal wall of 1.5–2 cm in diameter,
with a hyperemia halo, painful during palpation, with abun-
dant white liquid discharge (Fig. 2a–c). Oncologic cytology of
the vaginal cupula, colposcopy and pathological anatomy was
performed, and the macroscopic material collected consisted
of 3 irregular fragments of tissue measuring 0.1–0.4 cm,  with
a smooth elastic appearance and brownish color. The mate-
rial was ﬁxed in 10% formol and submitted to the B1 and
F3 exam, and the result was: chronic unspeciﬁc colpitis
in an acute attack on the side of the ﬁbrino leukocytic
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Fig. 1 – (a–f) Clinical intraoral exam, multiple ulcers measuring approximately 0.5–1.2 cm in diameter, with an erythematous
, lipshalo and ﬁbrinolytic bed on the edge and back of the tongue
crust, outcrops of erosion, exocytosis and spongiosis; posi-
tive vaginal and urethral culture for enterococcus sp, negative
FAN/anti DNA and rheumatoid factor lower than 20. Non-
reagent serology for syphilis (VDRL) and anti HIV 1 and anti
HIV 2 also non-reagent, was performed. Seric dosage of T3
(triiodothyronine = 1449 ng/dL), T4 (thyroxine = 7.9 ng/dL), TSH
(thyrostimulant hormone = 3.4 mUI/ml), free T4 (free thyroxine
fraction = 1.1 ng/dL), LH (luteinizing hormone = 8.0 mUI/ml),
and FSH (follicle stimulant hormone = 4.4 mUI/ml) was per-
formed and all the results presented were within the
normality parameters. The seric dosage of alpha-1 acid glyco-
protein resulted in a conﬁrmed value of 234 mg/dL (reference
value 30–120 mg/dL).
Fig. 2 – (a–c) Multiple ulcerations of the posterior vaginal wall of 
palpation, with abundant white liquid discharge. and bilateral jugal mucosa.
The patient also reported that when having sexual
relations in this phase of the treatment, she presented dys-
pareunia and afterwards the uterine cervix wall ruptured, and
surgical intervention was required to repair it. The patient was
medicated with 20 mg/day prednisone for 15 days and then
doses of 15 mg/day for a further 15 days, followed by 10 mg/day
for 1 month. The pre-existent condition of all the symptoms
having disappeared, the patient was kept under observation.
After the treatment was interrupted and the patient was
kept under observation, 5 months later, the patient presented
new less aggressive episodes of oral and genital lesions, but
at this time the joint pains had intensiﬁed, making it difﬁ-
cult for her to walk, and ophthalmic lesions began to occur.
1.5–2 cm in diameter, with a hyperemia halo, painful on
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he patient complained of a discreet loss of visual acu-
ty and reddened, burning eyes. On clinical ophthalmologic
xam the patient presented with non-granulomatose bilat-
ral intra-ocular inﬂammation characterizing the condition
f retinitis and non-exuberant intra-retinal hemorrhages in
he depth of the eye, conﬁrming the diagnosis as uveitis.
oon afterwards, blister-like vesico lesions, erythematosus
nd extremely painful multiple lesions, measuring approx-
mately 0.4–0.8 cm in diameter appeared unilaterally in the
nfra-mammary and intercostal region and were diagnosed as
erpes Zosters.
At this time, the use of prednisone was started
ith 60 mg/day on the ﬁrst day, 50 mg/day on the sec-
nd day, 40 mg/day on the third day, 30 mg/day on the fourth
ay, 20 mg/day on the ﬁfth day and kept at 10 mg/day up to the
resent time. Concomitantly aciclovir (Zovirax – 200 mg/day)
as also administered, with complete remission of the
esions, but the painful reactions to touch at the sites that
anifested Herpes Zosters lesions were still present.
In accordance with the criteria of the International Group
or diagnosing the Behc¸et’s syndrome, the patient ﬁts in with
he criteria, with the presence of oral, genital, ophthalmic and
rthopedic manifestations, her diagnosis being compatible
ith the said syndrome.
iscussion
he SB is a chronic inﬂammatory disease characterized by
enital, ocular, cutaneous, orthopedic, gastrointestinal and
eurological manifestation. The International Study Group for
ehc¸et’s Disease recommends that in the diagnosis of the
isease it is necessary to present oral lesions (recurrent oral
lcers) associated with two more  manifestation: ocular, gen-
tal, and cutaneous or rheumatoid arthritis (arthralgia), and
hus need to be investigated properly through good anamnesis
nd multidisciplinary involvement to conﬁrm the diagnosis,
hich implies a broader dentists’s knowledge of the charac-
eristics of oral and systemic disease.2,3,10
Behc¸et’s syndrome is a disease that can reach serious pro-
ortions, may lead the patient to blindness and even death
ue to the complications of systemic manifestations mainly
phthalmological, neurological and pulmonary.11,12,15
Both for diagnosis and treatment, the multidisciplinary is
ssential because treatment can include medications in high
oses and criteria should be thoroughly evaluated to establish
atterns between beneﬁts and risks, leading the patient to the
isappearance of lesions, keeping it under stable conditions,
valuating the drug toxicity and physical conditions.13,14
The dentists should establish the best treatment in sync
ith the physicians involved in patient care, so that they
an effectively improve the oral complications without caus-
ng serious injury or interfere with the syndrome’s systemic
reatment.8,11,13,14
onclusionmphasis is laid on the importance of the dentist knowledge
bout the Behc¸et’s syndrome, its characteristics and its
orms of oral and general manifestations, as in view of the . 2 0 1 6;3  8(2):105–110 109
seriousness of this pathology and its similarity to other
diseases, it is difﬁcult to diagnose and treat. Due to its broad
clinical spectrum, multi-disciplinary treatment is important
to make an early and efﬁcient diagnosis, so as to prevent
aggravation and installation of the more  signiﬁcant and muti-
lating manifestations and to provide adequate treatment, in
order to offer the patient an improved quality of life.
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